jump to navigation

La insulina inhalada a punto de ser aprobada October 18, 2005

Posted by dstop in Noticias medicas.
trackback

Technosphere inhaled insulin is entering phase III clinical trials, according to manufacturer MannKind Corporation. Successful phase III trials are typically the last step before a drug is submitted to the U.S. FDA for regulatory review.

The drug, which was developed by insulin pump pioneer Al Mann, uses the proprietary MedTone inhaler device that administers the insulin. The inhaler fits in the palm of your hand and, all other things being equal, the convenience of the device over Exubera’s comparatively bulkier delivery system could be a big plus when it finally comes to market.

XXXLimagen
dLife Today:

Comments»

No comments yet — be the first.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: